StonvexLoading…
StonvexCore line items from SMSI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $17.36M | $20.55M | $40.86M | $48.51M |
Operating Income | $-29.01M | $-49.39M | $-18.05M | $-30.93M |
Net Income | $-29.33M | $-48.70M | $-24.40M | $-29.28M |
EPS (Diluted) | $-1.46 | $-3.94 | $-3.01 | $-0.53 |
Total Assets | $24.97M | $48.05M | $85.58M | $103.58M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.49M | $2.81M | $7.13M | $14.03M |
Free Cash Flow OCF − CapEx | $-7.28M | $-14.31M | $-6.98M | $-19.31M |
Shares Outstanding | 25.80M | 17.67M | 9.35M | 56.20M |